Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion type Assertion NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_head.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion wasGeneratedBy ECO_0000203 NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion wasDerivedFrom befree-20150227 NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion SIO_000772 23982433 NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion evidence source_evidence_literature NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.
- NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_assertion description "[The gain-of-function mutations in the PI3K p110 catalytic subunit (PIK3CA) have been identified in many cancers with a current global incidence of 26% (18-40%) in breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829457.RA2y81IGDQJ41lJOkdG-TgjQGLUEpzgKtqB5mvaxRVce0130_provenance.